AB 1990 would establish important consumer protection and safety standards for compounded GLP-1 and related weight-loss medications in California. As demand for these medications continues to grow, patients are increasingly encountering compounded versions through pharmacies, wellness clinics, and online marketing.

Unlike FDA-approved medicines, compounded drugs are not reviewed by the FDA for safety, quality, or effectiveness before reaching patients. Without stronger safeguards, Californians may face risks related to inconsistent dosing, impurities, contaminated ingredients, and misleading advertising.

This campaign supports stronger oversight, transparency, truthful advertising, and patient safety protections for compounded GLP-1 and weight-loss medications.

Take action today and urge California State Senators to support AB 1990.